We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.37% | 18.00 | 17.50 | 18.50 | 18.50 | 18.00 | 18.25 | 336,970 | 12:53:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/4/2017 09:13 | I'm amazed that GoFigure products are now available in 1300 retail outlets - am I reading that right? | someuwin | |
21/4/2017 09:12 | https://www.google.c | adnanwolf | |
21/4/2017 08:40 | Great report there Elrico,keep up the excellent work and please don't be put off with posters the likes of Lukead with stupid insensitive posts when he knows nothing of your personal circumstances and to cap it all most of his posts don't come across in good English as JJ pointed out with one y'day. | scotty1 | |
21/4/2017 08:25 | Another superbly comprehensive report by Elrico - great read and good to see that we may be ahead on the Sugars (info I don't remember seeing in the public domain beforehand).Many thanks for your hard work : )CheersSienna | siennadelekat21 | |
21/4/2017 08:23 | Chart-wise, the aim today is to stay above the body of yesterday's doji. So far, so good. M | marnewton | |
21/4/2017 08:05 | J J AND SCOTTY1, good, good, good, good news coming very soon, and I did say that I thought the share price would fall after the split, and yes I did Hoover up some more shares just in case the free skin share had a set date? But look back and you will see I said that I thought the share price would fall, but don't worry we will soon be back and looking up, and I will Hoover up a lot more at this price DIAMOND. | diamond fibre | |
21/4/2017 07:34 | I remember, elrico, because it was a screaming chart sell, with negative divergences all over the shop. That's the trouble with mixing fundamentals with charts, you stop trading what you see. Imminent news and freebie shares in SBTX kept me long. The story here seems quite compelling, so, having traded out last summer I'm holding and buying for the longer haul. Though I reserve the right to change my mind;¬) M Oh...and thanks for the report!¬) | marnewton | |
21/4/2017 06:37 | Bran - Are you confusing my 130p SB target at which I plan to take profits with a YE target? Let me ask you what are you base your 130p in 8 months on? If I was to offer any kind of a target outside on a public forum (outside of fun) I would attempt to qualify it and cover my back with a caveat or two. Targets have a nasty habit of making even the experienced look foolish. I recently suggested 90p by LP-LDL launch, I was within a gnats chuff of it only for it to reverse. I now look an idiot. Nobody will remember it hit 90p intraday. | elrico | |
21/4/2017 00:44 | Elrico in your opinion is it realistic to aim for a share price of £1.30 by year end? That is my target. | branboyd1 | |
21/4/2017 00:40 | Slartybartfast - How can I remain angry with you, I love HGTTG. Ref sugars; I don't have more info at this stage. As I point out in the article, OPTI is effectively several companies within one holding company, of course they are platforms and each need particular attention to detail. I am sure sweetbiotix is another report in the making but that is for the future and I have to be careful not to overstep my boundaries with SOH. We are at a very delicate stage and exciting times are ahead, though appreciate the share price may well suggest otherwise. SOH excitement for LP-LDL and Slimbiome is evident, though I would guard about reading too much into this in terms of the results on 25th - in the case of Slimbiome. However, I was very surprised to learn GoFigure added over 500 retail listings since my March article. This was the only edit SOH suggested, because I used my now out of date figure of 800 retail listings. It is clear there is much happening behind the scenes and I'm sure SOH would love to sing about it but cannot. | elrico | |
20/4/2017 23:59 | Elrico, the enthusiasm for slimbiome ldl is very encouraging. Great perspective and the sugar news was not expected at all, i was expecting sugar mid or late next year. This suggests sugar tests have already been completed and negotiations very close it not concluded. Have you any more info on this. I feel a silly asking after reading such a detailed report. Thanks again and thanks for being humble after me being a idiot. | slartybartfaster | |
20/4/2017 23:10 | We made hard work of it. Job done though :) | elrico | |
20/4/2017 23:05 | Nice one Elric, Great result tonight as well :) | judijudi | |
20/4/2017 23:04 | Bran - Finncap and their No's 020 7220 0500 :) | elrico | |
20/4/2017 22:56 | I will be excited when a reputable source such as Finncap publish their report. Hopefully it will include some numbers too. | branboyd1 | |
20/4/2017 22:53 | Nice one elrico, well researched and informative. Nothing but appreciation should be shown for generously sharing what you have learned from your time.Next month opti are beginning the commercial phase. Slimbiome, cholbiome snd cardiobiome will be seriously launched. Finally it should mark the beginning of the end of those consistently asking a company in its development phase where the revenues are. Per & Christina have phenomenal records and their arrival reinforces the transformation from rnd to Commercial. Lpldl with its unique blood pressure/cholesterol reducing ability, its 0.1g just just as efficacious than the 2g+ required by the market leader, and its exceptionally low cost of production due to only consisting of a single strain.....if opti show some early sales the corporates will be all over lpldl like s rash and I have no doubt they are watching. It's a completely different discussion talking about distribution when there is actually a product to distribute. The interest seen at this early stage is a huge sign of what's to come. | riskybusiness1 | |
20/4/2017 22:36 | Lemming Investor...sounds an ify newsletter. Where they any good? | incanus | |
20/4/2017 22:32 | Thanks Elric, another informative and well presented report. I am very grateful to you for sharing such documents. | rafboy | |
20/4/2017 22:28 | ...Ah yes - the good old Lemming Investor days. I used to enjoy those newsletters. | someuwin | |
20/4/2017 22:09 | I have worked with Elric on a number of projects and to be frank, i really do not know how he pulls it off. Those reports would have been excruciatingly difficult and time consuming to compose. Dyslexic people often have strong visual, creative and problem solving skills and are prominent among entrepreneurs, inventors, architects, engineers and in the arts and entertainment world. Many famous and successful people are dyslexic. I appreciate Elric's is a mild form even a word processor is not a great help at times. The first report i read of Elric's was on ASOS, it was littered with spelling errors but lacked none of the detail needed to make an informed decision. I made a mint and pleaded to work with him. It was short lived, just 3 very productive years. I would happily pay good money for those reports in the header. | scrutable | |
20/4/2017 21:24 | ...Updated. | someuwin | |
20/4/2017 21:02 | Someuwin - new link. Cheers | elrico | |
20/4/2017 20:45 | Good work again Elrico. Have added to header. | someuwin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions